|drug1838||Local standard of care Wiki||1.00|
|D051436||Renal Insufficiency, Chronic NIH||0.58|
|D007154||Immune System Diseases NIH||0.45|
|D007674||Kidney Diseases NIH||0.45|
There is one clinical trial.
Data show that the coronavirus disease 2019 (COVID-19) symptoms can be severe in 4% and 3% of the adolescents aged 11-15 years and ≥ 16 years, respectively. In addition, the prevalence of chronic diseases among adolescents has increased in the last years. About 20% of the adolescents have some chronic disease, resulting in increased morbidity and mortality. In march, 2020, the quarantine was officially implemented in Sao Paulo, while elective medical appointments for adolescents with chronic disease were temporarily suspended. To mitigate the deleterious effect of the social isolation on physical and mental health among these patients, this study aims to test the effects of an online, home-based, exercise training program.
Description: Semi structured interviewMeasure: Safety and efficacy of a home-based exercise training program Time: From baseline to 3 months of follow-up
Description: Semi structured interviewMeasure: Patients perceptions during social isolation Time: From baseline to 3 months of follow-up
Description: Quality of life will be assessed by means of Pediatric Quality of Life inventory (PedsQLTM 4.0)Measure: Adolescents quality of life Time: From baseline to 3 months of follow-up
Description: Will be assessed by means of a visual analog scale (from 0 - no disease activity) to 10 - maximum disease activity).Measure: Disease activity Time: From baseline to 3 months of follow-up
Description: Will be assessed using the visual analog scale from 0 (very good condition) to 10 (very poor condition).Measure: Disease overall assessment Time: From baseline to 3 months of follow-up
Description: Will be assessed by means of Strengths & Difficulties QuestionnairesMeasure: Strengths and difficulties Time: From baseline to 3 months of follow-up
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports